Advertisement
BD Biosciences
BD Biosciences

Most Recent

image: Ancient Viruses Wreak New Havoc

Ancient Viruses Wreak New Havoc

By | October 24, 2012

Viral DNA in mice genomes may lead to cancer in immune-compromised animals.

2 Comments

image: Cell Re-Programmers Take the Nobel

Cell Re-Programmers Take the Nobel

By | October 8, 2012

John B. Gurdon and Shinya Yamanaka win this year’s Nobel Prize in Medicine for learning how to reboot cellular development. 

7 Comments

image: Cell Reprogramming Work Wins Nobel

Cell Reprogramming Work Wins Nobel

By | October 8, 2012

John B. Gurdon and Shinya Yamanaka jointly take home this year’s Nobel Prize in Medicine for turning back the developmental clock. 

0 Comments

image: Drug Allergy in the Pocket

Drug Allergy in the Pocket

By | October 1, 2012

An HIV drug can bind to and alter the function of an immune molecule, causing a dangerous reaction in patients with a particular allele.

0 Comments

image: 2012 Labbies Honorable Mentions

2012 Labbies Honorable Mentions

By | October 1, 2012

Check out other memorable images and videos that were submitted to this year’s Labby Multimedia Awards.

0 Comments

image: A Good Night’s Sleep

A Good Night’s Sleep

By | September 1, 2012

Sleep-wake cycles affect how well our bodies fight disease.

0 Comments

image: Stemming the Toxic Tide

Stemming the Toxic Tide

By | September 1, 2012

How to screen for toxicity using stem cells

1 Comment

image: Creating Sperm from Skin

Creating Sperm from Skin

By | August 30, 2012

Researchers create early stage sperm cells from induced pluripotent stem cells, raising hopes that infertile men could be fathers.

0 Comments

image: The Danger of Vaccine Exemptions

The Danger of Vaccine Exemptions

By | August 30, 2012

Are states with less rigorous rules about which children can claim an exception from vaccination in kindergarten putting communities at higher risk of childhood disease?

4 Comments

image: Clinical Trial Misfortune

Clinical Trial Misfortune

By | August 28, 2012

A human trial of a hepatitis C treatment is shut down after one of the participants died.

1 Comment

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement
LI-COR
LI-COR

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
Advertisement
Molecular Devices
Molecular Devices
Life Technologies